BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees6,772
Employees6,772
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees6,772
Employees6,772
BNTX Key Statistics
Market cap22.03B
Market cap22.03B
Price-Earnings ratio-34.82
Price-Earnings ratio-34.82
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$93.76
High today$93.76
Low today$91.26
Low today$91.26
Open price$92.43
Open price$92.43
Volume938.69K
Volume938.69K
52 Week high$129.27
52 Week high$129.27
52 Week low$81.20
52 Week low$81.20
Stock Snapshot
The current BioNTech SE(BNTX) stock price is $91.60, with a market capitalization of 22.03B. The stock trades at a price-to-earnings (P/E) ratio of -34.82.
During the trading session on 2025-12-17, BioNTech SE(BNTX) shares reached a daily high of $93.76 and a low of $91.26. At a current price of $91.60, the stock is +0.4% higher than the low and still -2.3% under the high.
Trading volume for BioNTech SE(BNTX) stock has reached 938.69K, versus its average volume of 1.21M.
The stock's 52-week range extends from a low of $81.20 to a high of $129.27.
The stock's 52-week range extends from a low of $81.20 to a high of $129.27.
Analyst ratings
77%
of 22 ratingsBuy
77.3%
Hold
22.7%
Sell
0%